Susquehanna International Group’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $259K | Buy |
18,512
+1,776
| +11% | +$23.9K | ﹤0.01% | 11183 |
|
|
2025
Q4 | $188K | Sell |
16,736
-16,717
| -50% | -$191K | ﹤0.01% | 10949 |
|
|
2025
Q3 | $387K | Sell |
33,453
-32,877
| -50% | -$385K | ﹤0.01% | 9554 |
|
|
2025
Q2 | $812K | Sell |
66,330
-5,891
| -8% | -$74.1K | ﹤0.01% | 7976 |
|
|
2025
Q1 | $1.03M | Buy |
72,221
+50,133
| +227% | +$783K | ﹤0.01% | 7174 |
|
|
2024
Q4 | $352K | Buy |
+22,088
| New | +$437K | ﹤0.01% | 9477 |
|
|
2024
Q3 | – | Sell |
-19,531
| Closed | -$389K | – | 11939 |
|
|
2024
Q2 | $389K | Buy |
+19,531
| New | +$380K | ﹤0.01% | 8865 |
|
|
2024
Q1 | – | Sell |
-21,024
| Closed | -$472K | – | 12142 |
|
|
2023
Q4 | $472K | Buy |
21,024
+8,596
| +69% | +$177K | ﹤0.01% | 8813 |
|
|
2023
Q3 | $251K | Sell |
12,428
-2,366
| -16% | -$53.6K | ﹤0.01% | 9732 |
|
|
2023
Q2 | $378K | Sell |
14,794
-13,831
| -48% | -$364K | ﹤0.01% | 8964 |
|
|
2023
Q1 | $851K | Buy |
+28,625
| New | +$831K | ﹤0.01% | 7242 |
|
|
2022
Q4 | – | Sell |
-25,707
| Closed | -$560K | – | 12370 |
|
|
2022
Q3 | $560K | Buy |
+25,707
| New | +$672K | ﹤0.01% | 8186 |
|
|
2022
Q2 | – | Sell |
-7,305
| Closed | -$245K | – | 12843 |
|
|
2022
Q1 | $245K | Sell |
7,305
-1,954
| -21% | -$62.9K | ﹤0.01% | 10757 |
|
|
2021
Q4 | $321K | Buy |
+9,259
| New | +$299K | ﹤0.01% | 10315 |
|
|
2021
Q1 | – | Sell |
-22,275
| Closed | -$1.02M | – | 12212 |
|
|
2020
Q4 | $1.02M | Buy |
22,275
+15,222
| +216% | +$634K | ﹤0.01% | 6676 |
|
|
2020
Q3 | $234K | Buy |
7,053
+244
| +4% | +$7.8K | ﹤0.01% | 9197 |
|
|
2020
Q2 | $200K | Sell |
6,809
-16,838
| -71% | -$487K | ﹤0.01% | 9035 |
|
|
2020
Q1 | $637K | Buy |
23,647
+6,589
| +39% | +$197K | ﹤0.01% | 6404 |
|
|
2019
Q4 | $575K | Sell |
17,058
-5,565
| -25% | -$202K | ﹤0.01% | 6683 |
|
|
2019
Q3 | $847K | Buy |
22,623
+2,975
| +15% | +$113K | ﹤0.01% | 6067 |
|
|
2019
Q2 | $857K | Buy |
+19,648
| New | +$840K | ﹤0.01% | 6035 |
|
|
2018
Q3 | – | Sell |
-8,335
| Closed | -$536K | – | 9180 |
|
|
2018
Q2 | $477K | Buy |
+8,335
| New | +$440K | ﹤0.01% | 6885 |
|
|
2018
Q1 | – | Sell |
-26,839
| Closed | -$1.27M | – | 9285 |
|
|
2017
Q4 | $1.24M | Buy |
+26,839
| New | +$1.23M | ﹤0.01% | 4813 |
|
|
2017
Q3 | – | Sell |
-16,249
| Closed | -$693K | – | 8787 |
|
|
2017
Q2 | $638K | Buy |
+16,249
| New | +$614K | ﹤0.01% | 6179 |
|
|
2017
Q1 | – | Sell |
-70,930
| Closed | -$2.76M | – | 8910 |
|
|
2016
Q4 | $2.62M | Buy |
+70,930
| New | +$2.54M | ﹤0.01% | 3498 |
|
|
2016
Q1 | – | Sell |
-53,302
| Closed | -$1.42M | – | 8976 |
|
|
2015
Q4 | $1.78M | Buy |
53,302
+8,992
| +20% | +$280K | ﹤0.01% | 4274 |
|
|
2015
Q3 | $1.26M | Sell |
44,310
-65,624
| -60% | -$2.29M | ﹤0.01% | 5206 |
|
|
2015
Q2 | $4.45M | Sell |
109,934
-23,983
| -18% | -$1.08M | ﹤0.01% | 3102 |
|
|
2015
Q1 | $6.59M | Buy |
133,917
+127,706
| +2,056% | +$5.92M | ﹤0.01% | 2359 |
|
|
2014
Q4 | $282K | Buy |
+6,211
| New | +$244K | ﹤0.01% | 8226 |
|
Other funds holding AVNS
AC
VCM
VPM
Susquehanna International Group's AVNS Position: Q1 2026 in Review
Susquehanna International Group increased its Avanos Medical (AVNS) stake by 11% in Q1 2026, buying an estimated $23.9K and bringing the position to 18,512 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11183.
Susquehanna International Group first reported a position in AVNS in Q4 2014 and has held it in 30 quarters since. The position peaked at $6.59M in Q1 2015. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Susquehanna International Group held 18,512 shares of Avanos Medical worth $259K as of Q1 2026.
- Susquehanna International Group bought 1,776 Avanos Medical shares in Q1 2026, an estimated $23.9K.
- Avanos Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11183 holding.
- Susquehanna International Group first reported a position in Avanos Medical in Q4 2014 and has held it in 30 quarters since.
- Susquehanna International Group's Avanos Medical position peaked at $6.59M in Q1 2015.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.